These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7325722)

  • 1. [Comparative study of the in vitro anti-aggregating action of various salicylic derivatives].
    Sánchez MS; García Rafanell J; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):89-92. PubMed ID: 7325722
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet aggregation inhibition provoked by eterilate, benorylate and their molecular components, in comparison with acetylsalicylic acid].
    Ortega P; Alonso S; Navarro JL
    Arch Farmacol Toxicol; 1978 Apr; 4(1):150-2. PubMed ID: 29570
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effects of eterylate on "in vitro" Platelet function in human plasma (author's transl)].
    Ortega MP; Priego JG; Sunkel C; Armijo M
    Arch Farmacol Toxicol; 1980 Apr; 6(1):31-40. PubMed ID: 6104474
    [No Abstract]   [Full Text] [Related]  

  • 4. Alternatives to aspirin, derived from biological sources.
    Whitehouse MW; Rainsford KD; Ardlie NG; Young IG; Brune K
    Agents Actions Suppl; 1977; (1):43-57. PubMed ID: 343554
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological study of 2-phosphonoxybenzoic acid (fosfosal), a new analgesic drug.
    Rafanell JG; Bellés L; Sánchez MS; Forn J
    Arzneimittelforschung; 1980; 30(7):1091-8. PubMed ID: 6251858
    [No Abstract]   [Full Text] [Related]  

  • 6. Acetoxy benzene derivatives: in vitro antiaggregant activity.
    Dupin JP; Gravier D; Casadebaig F; Boisseau MR; Bernard H
    Farmaco Sci; 1986 Dec; 41(12):934-41. PubMed ID: 3556567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activity of eterilate, benorylate and acetylsalicylic acid on blood glucose in normal and experimentally diabetic rats].
    Alonso S; Ortega MP; Armijo M
    Arch Farmacol Toxicol; 1983 Aug; 9(2):183-90. PubMed ID: 6140900
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacological and biochemical study of a new non-narcotic analgesic: fosfosal (UR-1521)].
    García Rafanell J; Bellés L; Sánchez MS; Forn J
    Arch Farmacol Toxicol; 1981 Apr; 7(1):13-24. PubMed ID: 6976776
    [No Abstract]   [Full Text] [Related]  

  • 9. Inhibition of cyclooxygenase-2 expression by 4-trifluoromethyl derivatives of salicylate, triflusal, and its deacetylated metabolite, 2-hydroxy-4-trifluoromethylbenzoic acid.
    Fernández de Arriba A; Cavalcanti F; Miralles A; Bayón Y; Alonso A; Merlos M; García-Rafanell J; Forn J
    Mol Pharmacol; 1999 Apr; 55(4):753-60. PubMed ID: 10101034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [2-Arylidene 3,4-dihydro-1 (2H)-naphthalenones with potential platelet anti-aggregating activity: synthesis and structural and pharmacologic study].
    Varache-Beranger M; Nuhrich A; Devaux G; H'Naifi A; Carpy A
    Farmaco Sci; 1986 Feb; 41(2):156-67. PubMed ID: 3084294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological properties of eterylate, a new derivative of acetylsalicylic acid.
    Sunkel C; Cillero F; Armijo M; Piña M; Alonso S
    Arzneimittelforschung; 1978; 28(10):1692-4. PubMed ID: 39567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological studies of imidazole 2-hydroxybenzoate (ITF 182), an antiinflammatory compound with an action on thromboxane A2 production.
    Pagella PG; Bellavite O; Agozzino S; Donà GC; Cremonesi P; De Santis F
    Arzneimittelforschung; 1983; 33(5):716-26. PubMed ID: 6603228
    [No Abstract]   [Full Text] [Related]  

  • 13. 4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.
    Bayón Y; Alonso A; Sánchez Crespo M
    Br J Pharmacol; 1999 Mar; 126(6):1359-66. PubMed ID: 10217529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Synthesis and bioactivies of salicylic acid-g-chitosan derivatives].
    Wu XF; Li W; Wang L; Hu JM; Li GL
    Yao Xue Xue Bao; 2007 May; 42(5):481-7. PubMed ID: 17703768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultrastructural alterations of hepatic microbodies.
    Hruban Z; Swift H; Slesers A
    Lab Invest; 1966 Dec; 15(12):1884-901. PubMed ID: 4289682
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diflunisal inhibits inflammation and protects the stomach].
    Fischer M
    Med Klin Prax; 1982 Feb; 77(4):63-4, 72. PubMed ID: 7078501
    [No Abstract]   [Full Text] [Related]  

  • 17. [Antiphlogistic effect of salicylic acid and its derivatives].
    Binder M; Zeiller P
    Fortschr Med; 1993 Nov; 111(33):530-2. PubMed ID: 8307537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effect of salicylates on the toxicity of GABAlytics for mice].
    Golovko AI; Sofronov GA; Kliuntina TV
    Biull Eksp Biol Med; 1995 Jun; 119(6):619-20. PubMed ID: 8589387
    [No Abstract]   [Full Text] [Related]  

  • 19. [Salicylic acid derivatives used as anticoagulants].
    Bruhn HD
    Verh Dtsch Ges Inn Med; 1971; 77():1035-7. PubMed ID: 5155959
    [No Abstract]   [Full Text] [Related]  

  • 20. Acetylsalicylic acid: inhibition of platelet aggregation in the rabbit.
    Rosenberg FJ; Gimber-Phillips PE; Groblewski GE; Davison C; Phillips DK; Goralnick SJ; Cahill ED
    J Pharmacol Exp Ther; 1971 Nov; 179(2):410-8. PubMed ID: 5133610
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.